In this blog post we will explore the Comprehensive Diabetes Care HEDIS measure. .
What is New for 2020?
New measure Kidney Health Evaluation for Patient with Diabetes measure was added in 2020. This is a new measure. It evaluates the percent of members that are between 18 and 85 years of age that have diabetes and who received a kidney health evaluation, including estimated glomerular filtration gate test (eGFR) and a urine albumin-creating ration.
What is Comprehensive Diabetes Care Measure?
Measure that evaluates percentage of adult members between ages of 18 and 75 years of age (looks at both type 1 and type 2 diabetes) and who had each of the following:
HbA1c poor control (>9%)
HbA1c control of (<8%)
Retinal Eye Exam performed
Blood Pressure Control (<140/90 mm/Hg)\
Record your efforts: document results of, all of the above mentioned test, in the patient’s medical record.
How to meet this measure?
Provide reminders to patients for upcoming appointments and screenings.
Draw labs in your office if available or refer patients to a local lab for screenings.
Refer patients to participating eye professionals for annual retinal eye exams.
Follow up on lab test, eye exams and specialist referrals and document in your chart.
Telephone visits, e-visits and virtual check-ins are acceptable settings for blood pressure readings and should be recorded in the chart.
Include Category II reporting codes on claims to reduce the burden of HEDIS medical record review.
Educate patients on topics (for example, home monitoring of blood sugar and blood pressure, taking medications as prescribed, and other healthy lifestyle education like diet, exercise, and smoking cessation).
Like this type of content? Follow my blog for more free HEDIS, medical billing and coding guideline changes, medical/reimbursement policy changes.
Cervical cancer screening is measured by the percentage of women, 21 to 64 years of age who were screened for cervical cancer using either of the following criteria:
Women 21 to 64 years of age who had cervical cytology performed within the last 3 years.
Women 30 to 64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years.
Women 30 to 64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV) co-testing within the last 5 years.
Note: Evidence of hrHPV testing within the past five years also captures patients who had co-testing; therefore, additional methods to identify co-testing are not necessary.
For women age 24-64 as of Dec. 31 of the measurement year who had cervical cytology during the measurement year or the two years prior to the measurement year, documentation in the medical record must include both of the following: o A note indicating the date when the cervical cytology was performed o The result or finding
2. For women age 30-64 as of Dec. 31 of the measurement year who: 1) had cervical hrHPV testing during the measurement year or the four years prior to the measurement years, and 2) were 30 years or older as of the date of testing, documentation must include both: o A note indicating the date the hrHPV test was performed; generic documentation stating HPV test counts as evidence of hrHPV test o The results or findings
Documentation that will not be accepted for this measure:
Biopsies do not count
Lab results that state the sample was inadequate or that no cervical cells were present are not acceptable unless it is also stated this finding is consistent with a hysterectomy
Documenting hysterectomy is not sufficient; should note if the hysterectomy resulted in the loss of the cervix and include terms like total, complete or radical hysterectomy
1.Women who have had a total, complete or radical vaginal or abdominal hysterectomy with no residual cervix, cervical agenesis or acquired absence of cervix; prior to Dec. 31 of the measurement year 2. Hospice or palliative care during measurement years 3. Documentation of vaginal hysterectomy meets criteria for documentation of hysterectomy with no residual cervix
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). All summaries of the measures contained herein are reproduced w ith permission from HEDIS MY2020 and MY2021, Volume 2: Technical Specifications for Health Plans by the National Committee for Quality Assurance (NCQA). HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
Find this type op information useful? Follow my blog/website for more medical billing, coding guideline updates, reimbursement/medical coverage updates, HEDIS updates and more.
Definition: Comprehensive Diabetes Care HEDIS® Measure Retinal Eye Exam (DRE) is a percentage of patients between ages 18 to 75, with diabetes (type 1 and type 2), who had a retinal eye exam during the measurement year.
What is new?
The compliance of this measure is good for 2 years. You are allowed to bill the proper codes for the current measurement year, or prior year. This means you can submit the appropriate code at the time of the exam, and it covers both years.
Low risk for retinopathy (no evidence of retinopathy in the prior year). The codes can be used to indicate that retinopathy was not present the previous year.
Please make sure to document the following measurements in the patient’s medical records: HbA1c tests and results, retinal eye exam, blood pressure, urine creatinine test and the estimated glomerular filtration rate test.
DRE exams are an important component of in evaluating the overall health of diabetic patients. Providers should also strive to meet the Comprehensive Diabetes Care HEDIS measure with the following:
Hemoglobin A1c (HbA1c) testing
HbA1c poor control (>9.0%)
HbA1c control (<8.0%)
Retinal Eye exam performed
Blood Pressure control (<140/90 mm Hg)
Find this content helpful? Follow my blog for more of useful HEDIS Measures information!
Need on-demand training? Check out my On-demand training page and pre-register for the webinars!